Strykr Analysis
NeutralStrykr Pulse 52/100. Rally lacks conviction, skepticism is high, and risks are mounting. Threat Level 3/5.
If you want to see what peak disbelief looks like, just watch the tape at the close of March. U.S. stocks ripped higher on Tuesday, ending a brutal month with a flourish that would make even the most jaded permabull raise an eyebrow. The narrative du jour? Hopes for a U.S.-Iran truce. Never mind that the war is still raging and every credible geopolitical analyst is warning that ‘quick and tidy’ is not on the menu. The algos didn’t get the memo. They saw ‘truce’ in the headline and went haywire, hoovering up risk like the last hour of a Vegas bender.
MarketWatch and WSJ both led with the same theme: stocks are surging, but no one really believes it. The S&P 500, Dow, and Nasdaq all booked outsized gains, with chip and biotech names leading the charge. XLK, the tech sector ETF, closed at $132.94, flat on the day but up sharply from the month’s lows. DBC, the broad commodities ETF, was frozen at $28.97, a testament to how little conviction there is in the ‘reflation’ trade. The real story isn’t the rally. It’s the skepticism. Every major outlet is running some version of ‘stocks soar, but here’s why you shouldn’t trust it.’
The data is a mess. JOLTS numbers show a cooling labor market, with low hire and fire rates. Consumer sentiment is falling off a cliff. The Fed, meanwhile, is in full ‘nothing to see here’ mode. Barron’s points out that Fed officials are still talking up growth, even as the macro data gets gloomier by the week. The market’s wall of worry is now a full-on fortress, and yet, here we are, risk assets ripping higher into month-end. If you’re looking for logic, you’re in the wrong market.
Context is everything. The last time we saw this kind of disconnect between headlines and fundamentals was late 2021, right before the wheels came off the everything rally. Back then, it was Omicron. Now, it’s Iran. The difference is that this time, the Fed isn’t riding to the rescue. Rate cuts are off the table until the data really cracks. Meanwhile, the market is pricing in a Goldilocks scenario: war ends, inflation stays tame, and the Fed can keep rates steady. That’s a lot of ifs for one rally to carry.
The skepticism is warranted. ETFTrends.com points out that a quick end to the Iran war is looking less likely by the day. The market’s big problem, according to Seeking Alpha, is persistence, persistent inflation, persistent geopolitical risk, and now, persistent disbelief in every rally. The price of oil, which should be screaming higher if peace was really imminent, is stuck in neutral. DBC hasn’t moved in days. The only thing that’s moving is the narrative.
Analysis time. This rally feels like a short squeeze, not a conviction trade. The tape is thin, the volume is suspect, and the leadership is narrow. Chips and biotechs are leading, but the rest of the market is just along for the ride. The real tell is in the options market. Implied vols are creeping higher, not lower, even as stocks rip. That’s not what you see in a healthy bull market. That’s what you see when traders are hedging every uptick. The market is climbing a wall of worry, but the bricks are starting to wobble.
Strykr Watch
XLK closed at $132.94, just below key resistance at $133. If tech can break above $133 with volume, there’s room to run to $136. Support sits at $130, with a hard floor at $127. DBC is stuck at $28.97, with no momentum in either direction. Watch for a break above $29 for confirmation of a real reflation trade. The next big catalyst is the U.S. jobs report on April 3. If payrolls surprise to the upside, the rally could get legs. If not, expect a sharp reversal. RSI on XLK is neutral, but breadth is weak. Keep an eye on sector rotation, if chips start to roll over, the whole rally could unwind in a hurry.
The risk scenario is clear: the Iran truce hopes fade, the jobs data disappoints, and the Fed starts talking tough again. A break below $130 on XLK would invalidate the bull case. If DBC rolls over, it’s a sign that the macro bears are back in control. The biggest risk is that this rally is built on sand, a single bad headline could trigger a wave of selling as the skeptics finally get their day.
On the opportunity side, the play is to fade the rally into resistance. If XLK breaks above $133 with conviction, you can chase it to $136, but keep stops tight. If it fails, short with a target at $130. DBC is a wait-and-see, there’s no edge until it breaks out of its range. For the bold, look for sector rotation plays, if chips and biotechs start to lag, rotate into defensives or cash. The next big move will be dictated by the jobs report. Position accordingly.
Strykr Take
This rally is running on fumes and hope. The skepticism is justified, and the risk-reward is skewed to the downside. Strykr Pulse 52/100. Threat Level 3/5. If you’re chasing this tape, keep your stops tight and your skepticism tighter. The real move comes after the next data drop.
Sources (5)
Stocks surge, ending a tough month on a high note. But there's skepticism about the rally.
U.S. stocks surged Tuesday on growing optimistic about a potential end to the the Iran war.
Fed Officials Aren't Worried About Economic Growth. Are They Missing Something?
The optimism of Fed officials puts them somewhat at odds with a string of gloomy economic signals.
The Market Can Still Climb This Wall Of Worry - But Not Yet
I strongly believe this is a correction, not the start of a bear market. That said, I take a devil's advocate approach in this piece and focus on the
Markets Just Made History. 23 Stats That Prove It.
Barron's compiled a list of telling monthly and quarterly statistics with the Dow Jones Market Data team below.
Stock Market Rips Higher On Hopes For U.S.-Iran Truce; Chip, Biotech, Gold Stocks Lead The Way
The stock market powered higher Tuesday on the first day of its rally attempt as investors grew confident about a U.S.-Iran truce.